These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36502580)

  • 41. Endoplasmic Reticulum-Targeting Self-Assembly Nanosheets Promote Autophagy and Regulate Immunosuppressive Tumor Microenvironment for Efficient Photodynamic Immunotherapy.
    Huang PY; Liang SY; Xiang Y; Li MR; Wang MR; Liu LH
    Small; 2024 Jun; 20(25):e2311056. PubMed ID: 38377262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.
    Li L; Tian H; Zhang Z; Ding N; He K; Lu S; Liu R; Wu P; Wang Y; He B; Luo M; Peng P; Yang M; Nice EC; Huang C; Xie N; Wang D; Gao W
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):452-468. PubMed ID: 36538368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering antigen as photosensitiser nanocarrier to facilitate ROS triggered immune cascade for photodynamic immunotherapy.
    Wang H; Wang K; He L; Liu Y; Dong H; Li Y
    Biomaterials; 2020 Jun; 244():119964. PubMed ID: 32200102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
    Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
    J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs-Targeting Immunotherapy of Colon Cancer.
    Ding D; Zhong H; Liang R; Lan T; Zhu X; Huang S; Wang Y; Shao J; Shuai X; Wei B
    Adv Sci (Weinh); 2021 Jul; 8(14):e2100712. PubMed ID: 34021727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy.
    Liu Y; Deng F; Zheng R; Chen X; Zhao L; Yu B; Chen A; Jiang X; Cheng H; Li S
    J Colloid Interface Sci; 2022 Apr; 612():562-571. PubMed ID: 35026565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cell vaccine for the effective immunotherapy of breast cancer.
    Ni J; Song J; Wang B; Hua H; Zhu H; Guo X; Xiong S; Zhao Y
    Biomed Pharmacother; 2020 Jun; 126():110046. PubMed ID: 32145586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carrier-Free Nano-PROTACs to Amplify Photodynamic Therapy Induced DNA Damage through BRD4 Degradation.
    Zhao LP; Rao XN; Zheng RR; Huang CY; Kong RJ; Cheng H; Li B; Li SY
    Nano Lett; 2023 Jul; 23(13):6193-6201. PubMed ID: 37387510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Supramolecular Coassembled Peptide Hydrogels for Efficient Anticancer Therapy by RNS-Based PDT and Immune Microenvironment Regulation.
    Wang D; Li H; Wang D; Hao Y; Gui H; Liu J; Zhang Y; Liu J; Yang C
    Macromol Biosci; 2022 Dec; 22(12):e2200359. PubMed ID: 36208072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy.
    Zhou Z; Liu Y; Song W; Jiang X; Deng Z; Xiong W; Shen J
    J Control Release; 2022 Dec; 352():793-812. PubMed ID: 36343761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carrier Free Photodynamic Synergists for Oxidative Damage Amplified Tumor Therapy.
    Li XY; Deng FA; Zheng RR; Liu LS; Liu YB; Kong RJ; Chen AL; Yu XY; Li SY; Cheng H
    Small; 2021 Oct; 17(40):e2102470. PubMed ID: 34480417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
    Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
    Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear-Targeted Nanostrategy Regulates Spatiotemporal Communication for Dual Antitumor Immunity.
    Wang B; Hu ZC; Chen LJ; Liang HF; Lu HW; Chen Q; Liang B; Aji A; Dong J; Tian QW; Jiang LB; Xue FF
    Adv Healthc Mater; 2024 Feb; 13(4):e2302342. PubMed ID: 37975509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Facile Low-Dose Photosensitizer-Incorporated Dissolving Microneedles-Based Composite System for Eliciting Antitumor Immunity and the Abscopal Effect.
    Bian Q; Huang L; Xu Y; Wang R; Gu Y; Yuan A; Ma X; Hu J; Rao Y; Xu D; Wang H; Gao J
    ACS Nano; 2021 Dec; 15(12):19468-19479. PubMed ID: 34859990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
    Chin YC; Yang LX; Hsu FT; Hsu CW; Chang TW; Chen HY; Chen LY; Chia ZC; Hung CH; Su WC; Chiu YC; Huang CC; Liao MY
    J Nanobiotechnology; 2022 Aug; 20(1):373. PubMed ID: 35953837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
    Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
    Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photoswitchable dynamics and RNAi synergist with tailored interface and controlled release reprogramming tumor immunosuppressive niche.
    Xiong H; Song Z; Wang T; Huang K; Yu F; Sun W; Liu X; Liu L; Jiang H; Wang X
    Biomaterials; 2025 Jan; 312():122712. PubMed ID: 39098305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.